[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1732 Introduced in House (IH)]

<DOC>






115th CONGRESS
  1st Session
                                H. R. 1732

    To amend the Controlled Substances Act to add certain synthetic 
           substances to schedule I, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 27, 2017

  Mr. Dent (for himself, Mr. Himes, and Mr. Barletta) introduced the 
   following bill; which was referred to the Committee on Energy and 
  Commerce, and in addition to the Committee on the Judiciary, for a 
 period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL


 
    To amend the Controlled Substances Act to add certain synthetic 
           substances to schedule I, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Synthetic Drug Control Act of 
2017''.

SEC. 2. TREATMENT OF CERTAIN DESIGNER DRUGS AS SCHEDULE I CONTROLLED 
              SUBSTANCES.

    (a) In General.--Not later than 180 days after the date of 
enactment of this Act, the Attorney General of the United States shall 
update schedule I under section 202(c) of the Controlled Substances Act 
(21 U.S.C. 812(c)) to include, unless specifically exempted or unless 
listed in another schedule, any material, compound, mixture, or 
preparation which contains any quantity of a substance listed in 
paragraphs (1) through (9), or which contains the salts, isomers, and 
salts of isomers thereof whenever the existence of such salts, isomers, 
and salts of isomers is possible within the specific chemical 
designation. The substances referred to in the preceding sentence are 
the following:
            (1) Phenylalkylamines.--The substances listed in this 
        paragraph consist of the following phenylalkylamines:
                    (A) 1-(4-Ethylphenyl)-2-(methylamino)-1-propanone.
                    (B) 1-(4-Methoxyphenyl)-2-(methylamino)-1-
                propanone.
                    (C) 2-(Ethylamino)-1-(4-methoxyphenyl)-1-propanone.
                    (D) 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)-1-
                propanone.
                    (E) 2-(Ethylamino)-1-phenyl-1-propanone.
                    (F) 1-Phenyl-2-(1-pyrrolidinyl)-1-propanone.
                    (G) 1-(4-Methoxyphenyl)-2-(1-pyrrolidinyl)-1-
                propanone.
                    (H) 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-
                propanone.
                    (I) 2-Amino-1-(4-fluorophenyl)propan-1-one.
                    (J) 2-(Ethylamino)-1-(4-ethylphenyl)-1-propanone.
                    (K) 2-(Dimethylamino)-1-phenyl-1-propanone.
                    (L) 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-
                butanone.
                    (M) 1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-
                hexanone.
                    (N) 2-(Methylamino)-1-phenyl-1-butanone.
                    (O) 2-(Methylamino)-1-(4-methylphenyl)-1-butanone.
                    (P) 1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-
                butanone.
                    (Q) 1-(3,4-Dimethylphenyl)-2-(methylamino)-1-
                propanone.
                    (R) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-
                propanone.
                    (S) 2-(Benzylamino)-1-(4-methylphenyl)-1-propanone.
                    (T) 1-(1-Naphthyl)-2-(1-pyrrolidinyl)-1-pentanone.
                    (U) 1-(1,3-Benzodioxol-5-yl)-2-(benzylamino)-1-
                propanone.
                    (V) 1-(1,3-Benzodioxol-5-yl)-2-(benzylamino)-1-
                butanone.
                    (W) 1-(1,3-Benzodioxol-2-yl)-2-(N-hydroxy-N-
                methylamino)-1-propanone.
                    (X) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-
                butanone.
                    (Y) 2-(Ethyl(methyl)amino)-1-phenylbutan-1-one.
                    (Z) 1-(4-Bromophenyl)-2-(methylamino)-1-propanone.
                    (AA) 2-[Ethyl(methyl)amino]-1-phenyl-1-propanone.
                    (BB) 2-(Methylamino)-1-(3-methylphenyl)-1-
                propanone.
                    (CC) 2-(1-Pyrrolidinyl)-1-(2-thiophenyl)-1-
                pentanone.
                    (DD) 1-(4-Fluorophenyl)-2-(methylamino)-1-butanone.
                    (EE) 1-(4-Methoxyphenyl)-2-(1-pyrrolidinyl)-1-
                butanone.
                    (FF) 1-(4-Ethylphenyl)-2-(1-pyrrolidinyl)-1-
                butanone.
                    (GG) 1-(4-Methoxy-3-methylphenyl)-2-(methylamino)-
                1-propanone.
                    (HH) 2-(Ethylamino)-1-(3-methylphenyl)-1-propanone.
                    (II) 2-Amino-1-(1H-indol-5-yl)-1-propanone.
                    (JJ) 1-Phenyl-2-(1-piperidinyl)-1-butanone.
                    (KK) 2-(Methylamino)-1-(2,4,5-trimethylphenyl)-1-
                propanone.
                    (LL) 1-Phenyl-2-(1-pyrrolidinyl)-1-heptanone.
                    (MM) 1-Phenyl-2-(1-pyrrolidinyl)-1-hexanone.
                    (NN) 1-(4-Fluorophenyl)-2-(1-pyrrolidinyl)-1-
                pentanone.
                    (OO) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-
                pentanone.
                    (PP) 1-(2-Fluorophenyl)-N-methyl-2-propanamine.
                    (QQ) 1-(2-Fluorophenyl)-2-propanamine.
                    (RR) 1-(3-Fluorophenyl)-2-propanamine.
                    (SS) 1-(3-Fluorophenyl)-N-methyl-2-propanamine.
                    (TT) 1-(4-Fluorophenyl)-2-propanamine.
                    (UU) 1-(4-Fluorophenyl)-N-methyl-2-propanamine.
                    (VV) 1-(4-Methylphenyl)-2-propanamine.
                    (WW) N-Ethyl-N-methyl-1-phenyl-2-propanamine.
                    (XX) 1-(1-Benzofuran-4-yl)-2-propanamine.
                    (YY) 1-(1-Benzofuran-5-yl)-2-propanamine.
                    (ZZ) 1-(2,3-Dihydro-1-benzofuran-5-yl)-2-
                propanamine.
                    (AAA) 1-(1-Benzofuran-6-yl)-2-propanamine.
                    (BBB) 1-(2,3-Dihydro-1-benzofuran-6-yl)-2-
                propanamine.
                    (CCC) 1-(4-Methoxyphenyl)-N-methyl-2-propanamine.
                    (DDD) N,N-Dimethyl-1-phenyl-2-propanamine.
                    (EEE) 1-(2,3-Dihydro-1H-inden-5-yl)-2-propanamine.
                    (FFF) 5,6,7,8-Tetrahydronaphtho[2,3-d][1,3]dioxol-
                6-amine.
                    (GGG) 1-[4-(Methylsulfanyl)phenyl]-2-propanamine.
                    (HHH) 1-(4-Chlorophenyl)-2-propanamine.
                    (III) 1-(2,4,6-Trimethoxyphenyl)-2-propanamine.
                    (JJJ) 1-(2,4,5-Trimethoxyphenyl)-2-propanamine.
                    (KKK) 1-(2,5-Dimethylphenyl)-2-propanamine.
                    (LLL) 1-(3,4-Dimethylphenyl)-2-propanamine.
                    (MMM) N-(1-Phenyl-2-propanyl)-1-propanamine.
                    (NNN) 1-(1,3-Benzodioxol-5-yl)-N,N-dimethyl-2-
                propanamine.
                    (OOO) N-Ethyl-1-(4-methoxyphenyl)-2-propanamine.
                    (PPP) 1-(1-Benzofuran-5-yl)-N-methyl-2-propanamine.
                    (QQQ) 6,7-Dihydro-5H-indeno[5,6-d][1,3]dioxol-6-
                amine.
                    (RRR) 5-Iodo-2-indanamine.
                    (SSS) N-Methyl-6,7-dihydro-5H-indeno[5,6-
                d][1,3]dioxol-6-amine.
                    (TTT) N-Methyl-2-indanamine.
                    (UUU) 2-{4-[(2-Fluoroethyl)sulfanyl]-2,5-
                dimethoxyphenyl}ethanamine.
                    (VVV) 2-(8-Bromo-2,3,6,7-tetrahydrofuro[2,3-
                f][1]benzofuran-4-yl)ethanamine.
                    (WWW) 2-(2,5-Dimethoxy-3,4-
                dimethylphenyl)ethanamine.
                    (XXX) 2-(2,5-Dimethoxy-4-methylphenyl)-N-(2-
                methoxybenzyl)ethanamine.
                    (YYY) 2-(4-Ethyl-2,5-dimethoxyphenyl)-N-(2-
                methoxybenzyl)ethanamine.
                    (ZZZ) 2-(2,5-Dimethoxy-3,4-dimethylphenyl)-N-(2-
                methoxybenzyl)ethanamine.
                    (AAAA) 2-(2,5-Dimethoxyphenyl)-N-(2-
                methoxybenzyl)ethanamine.
                    (BBBB) 2-(2,5-Dimethoxy-4-nitrophenyl)-N-(2-
                methoxybenzyl)ethanamine.
                    (CCCC) 1-(8-Bromofuro[2,3-f][1]benzofuran-4-yl)-2-
                propanamine.
                    (DDDD) 1-(4-Chloro-2,5-dimethoxyphenyl)-2-
                propanamine.
                    (EEEE) 1-(8-Bromo-2,3,6,7-tetrahydrobenzo[1,2-
                b:4,5-b']difuran-4-yl)propan-2-amine.
                    (FFFF) 1-[4-(Ethylsulfanyl)-2,5-dimethoxyphenyl]-2-
                propanamine.
                    (GGGG) 1-(4-Ethoxy-2,5-dimethoxyphenyl)-2-
                propanamine.
                    (HHHH) 1-[2,5-Dimethoxy-4-(propylsulfanyl)phenyl]-
                2-propanamine.
                    (IIII) 6-Chloro-1,2,3,4-tetrahydro-1-
                naphthalenamine.
                    (JJJJ) N-Methyl-3-phenylbicyclo[2.2.1]heptan-2-
                amine.
                    (KKKK) 1-(2-Methoxyphenyl)-N-methyl-2-propanamine.
                    (LLLL) 2-[4-(Allyloxy)-3,5-
                dimethoxyphenyl]ethanamine.
                    (MMMM) 4-Methyl-2-hexanamine.
                    (NNNN) 4-Methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-
                amine.
                    (OOOO) N-Methyl-1-(2-thienyl)-2-propanamine.
                    (PPPP) 3-(Dimethylamino)-2,2-dimethylpropyl 4-
                aminobenzoate.
                    (QQQQ) 4-Methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-
                oxazol-2-amine.
                    (RRRR) 1-Phenyl-2-(1-pyrrolidinyl)-1-propanol.
            (2) Cannabimimetic agents.--The substances listed in this 
        paragraph consist of the following cannabimimetic agents:
                    (A) (4-Ethyl-1-naphthyl)(1-pentyl-1H-indol-3-
                yl)methanone.
                    (B) 2-(2-Methylphenyl)-1-(1-pentyl-1H-indol-3-
                yl)ethanone.
                    (C) (2-Methyl-1-[(1-methylpiperidin-2-yl)methyl]-6-
                nitro-1H-indol-3-yl)(2-naphthyl)methanone.
                    (D) (1-Butyl-1H-indol-3-yl)(4-
                methoxyphenyl)methanone.
                    (E) (1-Butyl-1H-indol-3-yl)(4-methyl-1-
                naphthyl)methanone.
                    (F) [1-(5-Fluoropentyl)-1H-indol-3-yl](4-methyl-1-
                naphthyl)methanone.
                    (G) {1-[(1-Methyl-2-piperidinyl)methyl]-1H-indol-3-
                yl}(1-naphthyl)methanone.
                    (H) 2-(3-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-
                yl)ethanone.
                    (I) (2-Iodophenyl){1-[(1-methyl-2-
                piperidinyl)methyl]-1H-indol-3-yl}methanone.
                    (J) Adamantan-1-yl{1-[(1-methyl-2-
                piperidinyl)methyl]-1H-indol-3-yl}methanone.
                    (K) 1-Naphthyl(1-propyl-1H-indol-3-yl)methanone.
                    (L) 5-[3-(1-Naphthoyl)-1H-indol-1-
                yl]pentanenitrile.
                    (M) 3-(1-Naphthylmethyl)-1-pentyl-1H-indole.
                    (N) (2-Methyl-1-propyl-1H-indol-3-yl)(1-
                naphthyl)methanone.
                    (O) 1-Naphthyl[1-(4-penten-1-yl)-1H-indol-3-
                yl]methanone.
                    (P) (4-Bromo-1-naphthyl)(1-pentyl-1H-indol-3-
                yl)methanone.
                    (Q) (4-Fluoro-1-naphthyl)(1-pentyl-1H-indol-3-
                yl)methanone.
                    (R) (1-Naphthyl)(1-phenyl-1H-indol-3-yl)methanone.
                    (S) [1-(5-Chloropentyl)-1H-indol-3-yl](2-
                iodophenyl)methanone.
                    (T) Adamantan-1-yl(1-pentyl-1H-indol-3-
                yl)methanone.
                    (U) (2-Iodo-5-nitrophenyl){1-[(1-methyl-2-
                piperidinyl)methyl]-1H-indol-3-yl}methanone.
                    (V) {1-[2-(4-Morpholinyl)ethyl]-1H-indol-3-
                yl}(2,2,3,3-tetramethylcyclopropyl)methanone.
                    (W) [1-(Tetrahydro-2H-pyran-4-ylmethyl)-1H-indol-3-
                yl](2,2,3,3-tetramethylcyclopropyl)methanone.
                    (X) N-(Adamantan-1-yl)-1-pentyl-1H-indole-3-
                carboxamide.
                    (Y) N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-
                indole-3-carboxamide.
                    (Z) [1-(5-Chloropentyl)-1H-indol-3-yl](2,2,3,3-
                tetramethylcyclopropyl)methanone.
                    (AA) [1-(3-Methylbutyl)-1H-indol-3-yl](1-
                naphthyl)methanone.
                    (BB) N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-
                indazole-3-carboxamide.
                    (CC) (1-Pentyl-1H-indol-3-yl)(4-propyl-1-
                naphthyl)methanone.
                    (DD) [1-(5-Chloropentyl)-1H-indol-3-yl](2,2,3,3-
                tetramethylcyclopropyl)methanone.
                    (EE) (4-Methyl-1-naphthyl)[1-(4-penten-1-yl)-1H-
                indol-3-yl]methanone.
                    (FF) (2-Methoxy-1-naphthyl)(1-pentyl-1H-indol-3-
                yl)methanone.
                    (GG) (3-Methoxyphenyl)(1-pentyl-1H-indol-3-
                yl)methanone.
                    (HH) (4-Ethyl-1-naphthyl)[1-(5-fluoropentyl)-1H-
                indol-3-yl]methanone.
                    (II) 8-Quinolinyl 1-(cyclohexylmethyl)-1H-indole-3-
                carboxylate.
                    (JJ) 1-(5-Fluoropentyl)-N-(1-naphthyl)-1H-indole-3-
                carboxamide.
                    (KK) N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-(4-
                fluorobenzyl)-1H-indazole-3-carboxamide.
                    (LL) N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-
                pentyl-1H-indole-3-carboxamide.
                    (MM) (2-Iodophenyl)(1-pentyl-1H-indol-3-
                yl)methanone.
                    (NN) [5-(2-Methylphenyl)-1-pentyl-1H-pyrrol-3-
                yl](1-naphthyl)methanone.
                    (OO) N-(1-Naphthyl)-1-pentyl-1H-indole-3-
                carboxamide.
                    (PP) [1-(5-Chloropentyl)-1H-indol-3-yl](4-methyl-1-
                naphthyl)methanone.
                    (QQ) (4-Methyl-1-naphthyl)(2-methyl-1-pent-4-enyl-
                1H-indol-3-yl)methanone.
                    (RR) (2-Methylphenyl)[1-(5-fluoropentyl)-1H-indol-
                3-yl]methanone.
                    (SS) (2-Ethylphenyl)[1-(5-fluoropentyl)-1H-indol-3-
                yl]methanone.
                    (TT) [1-(5-Chloropentyl)-1H-indol-3-yl](1-
                naphthyl)methanone.
                    (UU) [1-(5-Bromopentyl)-1H-indol-3-yl](1-
                naphthyl)methanone.
                    (VV) {1-[(1-Methyl-2-piperidinyl)methyl]-1H-indol-
                3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone.
                    (WW) [1-(1-Methylazepan-2-yl)-1H-indol-3-
                yl](2,2,3,3-tetramethylcyclopropyl)methanone.
                    (XX) 4-Hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-
                indol-3-yl)-1-pentanone.
                    (YY) [1-(4-Fluoropentyl)-1H-indol-3-yl](1-
                naphthyl)methanone.
                    (ZZ) 2-(2-Iodophenyl)-1-(1-pentyl-1H-indol-3-yl)-1-
                ethanone.
                    (AAA) (2,2,3,3-Tetramethylcyclopropyl)(1-butyl-1H-
                indol-3-yl)methanone.
                    (BBB) (2,2,3,3-Tetramethylcyclopropyl)[1-(4,4,4-
                trifluorobutyl)-1H-indol-3-yl]methanone.
                    (CCC) 7-Methoxy-1-[2-(4-morpholinyl)ethyl]-N-
                [(1S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-
                indole-3 -carboxamide.
                    (DDD) 8-Quinolinyl 1-(4-fluorobenzyl)-1H-indole-3-
                carboxylate.
                    (EEE) 1-Naphthyl 1-(4-fluorobenzyl)-1H-indole-3-
                carboxylate.
                    (FFF) N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-
                (5-fluoropentyl)-1H-indole-3-carboxamide.
                    (GGG) [1-(4-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-
                tetramethylcyclopropyl)methanone.
                    (HHH) 1-Naphthyl(1-pentyl-1H-indazol-3-
                yl)methanone.
                    (III) N-(1-Naphthyl)-1-pentyl-1H-indazole-3-
                carboxamide.
                    (JJJ) 1-Naphthyl 1-(5-fluoropentyl)-1H-indole-3-
                carboxylate.
                    (KKK) Methyl 3-methyl-2-[(1-pentylindazole-3-
                carbonyl)amino]butanoate.
                    (LLL) Methyl 2-[[1-(5-fluoropentyl)indazole-3-
                carbonyl]amino]-3-methylbutanoate.
                    (MMM) N-Benzyl-1-pentyl-1H-indole-3-carboxamide.
                    (NNN) N-Benzyl-1-(5-fluoropentyl)-1H-indole-3-
                carboxamide.
                    (OOO) Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-
                indazol-3-yl}formamido)-3-methylbutanoate.
                    (PPP) 8-Quinolinyl 1-pentyl-1H-indazole-3-
                carboxylate.
                    (QQQ) 8-Quinolinyl 1-(5-fluoropentyl)-1H-indazole-
                3-carboxylate.
                    (RRR) 2-Naphthyl 1-(2-fluorophenyl)-1H-indazole-3-
                carboxylate.
                    (SSS) [1-(4-Fluorobenzyl)-1H-indol-3-yl](2,2,3,3-
                tetramethylcyclopropyl)methanone.
                    (TTT) 2-{[1-(5-Fluoropentyl)-1H-indol-3-
                yl]formamido}-3-phenylpropanamide.
                    (UUU) 2-{[1-(5-Fluoropentyl)-1H-indazol-3-
                yl]formamido}-3-phenylpropanamide.
                    (VVV) Methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-
                yl]formamido}-3-methylbutanoate.
                    (WWW) Methyl 2-[[1-(Cyclohexylmethyl)indazole-3-
                carbonyl]amino]-3,3-dimethylbutanoate.
                    (XXX) Methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-
                yl]formamido}-3,3-dimethylbutanoate.
                    (YYY) [1-(5-Fluoropentyl)-1H-benzimidazol-2-yl](1-
                naphthyl)methanone.
                    (ZZZ) [1-(4-Fluorobenzyl)-1H-indol-3-yl](1-
                naphthyl)methanone.
                    (AAAA) Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-
                indazol-3-yl}formamido)-3,3-dimethylbutanoate.
                    (BBBB) 8-Quinolinyl 1-(4-fluorobenzyl)-1H-indazole-
                3-carboxylate.
                    (CCCC) N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-
                indazole-3-carboxamide.
                    (DDDD) N-(1-Amino-3-methyl-1-oxo-2-butanyl)-1-(5-
                fluoropentyl)-1H-indole-3-carboxamide.
                    (EEEE) 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methyl-
                2-heptanyl)phenol.
                    (FFFF) 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methyl-
                2-dodecanyl)phenol.
                    (GGGG) 3-Hydroxy-2-[(1R)-6-isopropenyl-3-methyl-
                cyclohex-2-en-1-yl]-5-pentyl-1,4-benzoquinone.
                    (HHHH) {4-[2,6-Dimethoxy-4-(2-methyl-2-
                octanyl)phenyl]-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-
                yl}methanol.
                    (IIII) 1-Naphthyl[4-(pentyloxy)-1-
                naphthyl]methanone.
                    (JJJJ) 3-{[2-(Hydroxymethyl)-2,3-dihydro-1H-inden-
                4-yl]oxy}phenyl 4,4,4-trifluoro-1-butanesulfonate.
                    (KKKK) N-(1,3-Benzodioxol-5-ylmethyl)-7-methoxy-2-
                oxo-8-(pentyloxy)-1,2-dihydro-3-quinolinecarboxamide.
                    (LLLL) N-[3-(2-Methoxyethyl)-4,5-dimethyl-2,3-
                dihydro-1,3-thiazol-2-ylidene]-2,2,3,3-
                tetramethylcyclopropane-1-carboxamide.
                    (MMMM) [5-(2-Fluorophenyl)-1-pentyl-1H-pyrrol-3-
                yl](1-naphthyl)methanone.
                    (NNNN) 5-(4-Biphenylylmethyl)-N,N-dimethyl-1H-
                tetrazole-1-carboxamide.
                    (OOOO) 6-Methyl-2-[(4-methylphenyl)amino]-4H-3,1-
                benzoxazin-4-one.
                    (PPPP) 4-Hydroxy-N-[2-(4-hydroxyphenyl)ethyl]-3-
                (pentylamino)benzamide.
            (3) Arylcyclohexamines.--The substances listed in this 
        paragraph consist of the following arylcyclohexamines:
                    (A) 1-(3-Methoxyphenyl)-N-propylcyclohexanamine.
                    (B) 2-(Ethylamino)-2-(3-
                methoxyphenyl)cyclohexanone.
                    (C) 1-Phenylcyclohexanamine.
                    (D) 1-[1-(1-Benzothiophen-2-
                yl)cyclohexyl]piperidine.
                    (E) 1-[1-(4-Methylphenyl)cyclohexyl]piperidine.
                    (F) 1(4-Methoxyphenyl)-N-propylcyclohexanamine.
                    (G) 1-[1-(4-Methoxyphenyl)cyclohexyl]piperidine.
                    (H) 1-[1-(3-Methoxyphenyl)cyclohexyl]piperidine.
                    (I) 1-Phenyl-N-propylcyclohexanamine.
                    (J) N-(2-Methoxyethyl)-1-phenylcyclohexanamine.
                    (K) N-(2-Ethoxyethyl)-1-phenylcyclohexanamine.
                    (L) N-(3-Methoxypropyl)-1-phenylcyclohexanamine.
                    (M) 3-[1-(1-Piperidinyl)cyclohexyl]phenol.
                    (N) 2-(4-Methoxyphenyl)-2-
                (methylamino)cyclohexanone.
                    (O) 2-(2-Chlorophenyl)-2-(ethylamino)cyclohexanone.
            (4) Tryptamines.--The substances listed in this paragraph 
        consist of the following tryptamines:
                    (A) 2-(1H-Indol-3-yl)-N-methylethanamine.
                    (B) N-[2-(1H-Indol-3-yl)ethyl]-N-methyl-2-
                propanamine.
                    (C) N-[2-(1H-Indol-3-yl)ethyl]-N-isopropyl-2-
                propanamine.
                    (D) N-[2-(1H-Indol-3-yl)ethyl]-N-propyl-1-
                propanamine.
                    (E) 3-(2-(Diethylamino)ethyl)-1H-indol-4-yl 
                acetate.
                    (F) 3-{2-[Isopropyl(methyl)amino]ethyl}-1H-indol-4-
                ol.
                    (G) 3-[2-(Diisopropylamino)ethyl]-1H-indol-4-yl 
                acetate.
                    (H) 3-{2-[Isopropyl(methyl)amino]ethyl}-1H-indol-4-
                yl acetate.
                    (I) 3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl 
                acetate.
                    (J) 3-[2-(Diethylamino)ethyl]-1H-indol-4-ol.
                    (K) 3-[2-(Diisopropylamino)ethyl]-1H-indol-4-ol.
                    (L) 3-{2-[Ethyl(methyl)amino]ethyl}-1H-indol-4-ol.
                    (M) 3-{2-[Ethyl(methyl)amino]ethyl}-1H-indol-4-yl 
                acetate.
                    (N) 3-[2-(Dipropylamino)ethyl]-1H-indol-4-ol.
                    (O) 3-[2-(Dipropylamino)ethyl]-1H-indol-4-yl 
                acetate.
                    (P) N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)-N-
                methylpropan-2-amine.
                    (Q) 1-(5-Methoxy-1H-indol-3-yl)-2-propanamine.
                    (R) 3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl 
                acetate.
                    (S) N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N-
                propylpropan-2-amine.
                    (T) N,N-Diethyl-2-(5-methoxy-1H-indol-3-
                yl)ethanamine.
                    (U) N-Ethyl-2-(5-methoxy-1H-indol-3-yl)-N-
                methylethanamine.
            (5) Benzylpiperidines.--The substances listed in this 
        paragraph consist of the following benzylpiperidines:
                    (A) 2-(Diphenylmethyl)piperidine.
                    (B) 2-(Diphenylmethyl)pyrrolidine.
                    (C) Diphenyl(2-pyrrolidinyl)methanol.
                    (D) Methyl (3,4-dichlorophenyl)(2-
                piperidinyl)acetate.
                    (E) Methyl (3-chlorophenyl)(2-piperidinyl)acetate.
                    (F) Methyl (4-methylphenyl)(2-piperidinyl)acetate.
                    (G) Methyl (4-fluorophenyl)(2-piperidinyl)acetate.
                    (H) Ethyl phenyl(2-piperidinyl)acetate.
            (6) Benzodiazepines.--The substances listed in this 
        paragraph consist of the following benzodiazepines:
                    (A) 4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-
                thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine.
                    (B) 7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-
                benzodiazepin-2-one.
                    (C) 8-Bromo-1-methyl-6-phenyl-4H-
                [1,2,4]triazolo[4,3-a][1,4]benzodiazepine.
                    (D) 3-Methyl-6-[3-
                (trifluoromethyl)phenyl][1,2,4]triazolo[4,3-
                b]pyridazine.
            (7) Opioids and opioid-like substances.--The substances 
        listed in this paragraph consist of the following opioids and 
        opioid-like substances:
                    (A) 3-[2-(2-Amino-2-propanyl)-1-
                hydroxycyclohexyl]phenol.
                    (B) 2-Methyl-N-phenyl-N-[1-(1-phenyl-2-propanyl)-4-
                piperidinyl]propanamide.
                    (C) 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine.
                    (D) N-Phenyl-N-[1-(2-thiophenylethyl)-4-
                piperidinyl]acetamide.
            (8) Piperazines.--The substances listed in this paragraph 
        consist of the following piperazines:
                    (A) 1,4-Dibenzylpiperazine.
                    (B) 1-(4-Bromo-2,5-dimethoxybenzyl)piperazine.
                    (C) 1-(4-Fluorophenyl)piperazine.
                    (D) 1-(2-Methoxyphenyl)piperazine.
                    (E) 1-(4-Chlorophenyl)piperazine.
                    (F) 1-(4-Methoxyphenyl)piperazine.
                    (G) 1-(3-Methylbenzyl)piperazine.
                    (H) 1-Benzyl-4-methylpiperazine.
            (9) Tropane and alkaloids.--The substances listed in this 
        paragraph consist of the following tropane alkaloids:
                    (A) 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 4-
                fluorobenzoate.
                    (B) Methyl 3-(4-fluorophenyl)-8-methyl-8-
                azabicyclo[3.2.1]octane-2-carboxylate.
    (b) Inapplicability of Other Process and Considerations.--The 
Attorney General of the United States may carry out subsection (a) 
without regard to the process and considerations that are otherwise 
applicable under section 201 of the Controlled Substances Act (21 
U.S.C. 811) for adding, removing, or transferring controlled substances 
to, from, or among the schedules under section 202(c) of such Act (21 
U.S.C. 812(c)).
    (c) Exemption for Research.--
            (1) Exemption.--Notwithstanding subsection (a), a material, 
        compound, mixture, or preparation described in such subsection 
        shall not be treated as a controlled substance for purposes of 
        the Controlled Substances Act (21 U.S.C. 801 et seq.) so long 
        as the material, compound, mixture, or preparation is 
        manufactured, distributed, and used exclusively for qualified 
        research.
            (2) Qualified research defined.--In this subsection, the 
        term ``qualified research'' means research (as such term is 
        used in section 303(f) of the Controlled Substances Act (21 
        U.S.C. 823(f))) that is conducted by a practitioner who is 
        registered under such section 303(f) to conduct research with 
        controlled substances in schedule II, III, IV, or V (as 
        described in such section 303(f)).
    (d) Rule of Construction.--Nothing in this section shall be 
construed to limit or affect the authority of the Attorney General of 
the United States to add, remove, or transfer controlled substances to, 
from, or among the schedules under section 202(c) of the Controlled 
Substances Act (21 U.S.C. 812(c)), including controlled substances that 
have been added to a schedule pursuant to subsection (a).
                                 <all>